PNRR-POC-2022-12376049 - A composition comprising glucoraphanin, myrosinase and a buffered solution for use in the treatment of neurodegenerative diseases
PNRR Missione 6, Componente 2, Investimento 2.1 - "Rafforzamento e potenziamento della ricerca biomedica del SSN.
- Bando Ministero della Salute M6.C2.I2.1 Secondo bando Ministero della Salute M6.C2.I2.2
(POC Bando PNRR) verifies through nutritional studies the effect of a glucosinolate preparation on damage from neurodegenerative diseases.
FEM activity: untargeted and targeted metabolomic analysis (tryptophan metabolites, SCFA) on blood and urine samples, and extraction of glucosinolates from plant matrices.
Start Date
20/05/2023End Date
19/05/2025Funded by
Ministero della Salute 2022 - Proof of Concept Bando PNRRGrant agreement ID
PNRR-POC-2022-12376049Total cost
- budget
- 345,350.00 Euro
Coordinated by
Centro Neurolesi Bonino Pulejo Messina | IRCCS
Project description
PNRR Missione 6, Componente 2, Investimento 2.1 - "Rafforzamento e potenziamento della ricerca biomedica del SSN.
- Bando Ministero della Salute M6.C2.I2.1 Secondo bando Ministero della Salute M6.C2.I2.2
(POC Bando PNRR) verifies through nutritional studies the effect of a glucosinolate preparation on damage from neurodegenerative diseases.
FEM activity: untargeted and targeted metabolomic analysis (tryptophan metabolites, SCFA) on blood and urine samples, and extraction of glucosinolates from plant matrices.
FEM Project contact person
FEM staff involved
Funding Scheme
Europeo
Loghi